A comprehensive multi-omics study catalogues thousands of cancer-specific isoform switches in melanoma, ovarian cancer, and ...

CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and why treatment is still far away.

Researchers at Chongqing Medical University report that hypoxia silences the tumor suppressor CCNDBP1 in cervical cancer, ...

Neuroblastoma is the most common solid tumor found outside the brain in children, yet why some children respond well to ...

DNA typewriter maps mouse embryo development to reveal disease origins Barcode trail tracks cell family trees to pinpoint ...

A $25 million gift from the Smilow Foundation, led by William Smilow, will establish the Smilow Center for Precision ...

The programme will test how data collected continuously from wearable devices can be combined with patients' clinical ...

Three years ago, George Kassiotis and his team made an unexpected discovery: A specific way of producing a protein called calbindin was found to help cancer cells survive by preventing them from aging ...

CXO-level roundtable was facilitated by the Association of Biotechnology Led Enterprises (ABLE) ...

Prioritize viral vectors, oncology and rare disease therapies, with North America offering strong ROI potential through regulatory support, R&D investment and early adoptionDublin, Oct. 08, 2026 ...

Record global approvals, CRISPR breakthroughs, and expanding clinical and commercial activity are accelerating demand for cell and gene therapy tools and reagents.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE ...

The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a ...